US 11234932
Combination HIV therapeutic
granted A61KA61K31/167A61K31/19
Quick answer
US patent 11234932 (Combination HIV therapeutic) held by Aphios Corporation expires Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Aphios Corporation
- Grant date
- Tue Feb 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K31/167, A61K31/19, A61K31/20, A61K31/325